CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-13 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion | +11,757 | $14.47 | $170K | 34,039 |
| 2015-05-13 | DeSilva Nishan M VP, Finance & Strategy and CFO | Sale | −11,757 | $83.32 | $980K | 22,282 |
| 2015-05-13 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −11,757 | 64,029 | ||
| 2015-05-13 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −12,148 | 23,546 | ||
| 2015-05-12 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion | +14,214 | $14.47 | $206K | 36,496 |
| 2015-05-12 | DeSilva Nishan M VP, Finance & Strategy and CFO | Sale | −14,214 | $84.44 | $1.2M | 22,282 |
| 2015-05-12 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion | +9,306 | $21.92 | $204K | 31,588 |
| 2015-05-12 | DeSilva Nishan M VP, Finance & Strategy and CFO | Sale | −9,306 | $84.91 | $790K | 22,282 |
| 2015-05-12 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −14,214 | 75,786 | ||
| 2015-05-12 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −9,306 | 35,694 | ||
| 2015-04-24 | Sabba Stephen L Director | Grant or award | +925 | 26,622 | ||
| 2015-04-24 | Sabba Stephen L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | 2,754 | ||
| 2015-04-24 | KNOTT DAVID M Director | Grant or award | +925 | 70,152 | ||
| 2015-04-24 | KNOTT DAVID M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | 2,754 | ||
| 2015-04-24 | Patel Sunil Director | Grant or award | +925 | 38,025 | ||
| 2015-04-24 | Patel Sunil Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | $89.75 | $247K | 2,754 |
| 2015-04-24 | LAMATTINA JOHN L Director | Grant or award | +925 | 20,980 | ||
| 2015-04-24 | LAMATTINA JOHN L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | $89.75 | $247K | 2,754 |
| 2015-04-24 | KOZARICH JOHN W Director | Grant or award | +925 | 50,211 | ||
| 2015-04-24 | KOZARICH JOHN W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,754 | $89.75 | $247K | 2,754 |
Page 69 of 86 · 1,712 trades